Sumitomo Mitsui Construction Co Ltd
TSE:1821
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sumitomo Mitsui Construction Co Ltd
TSE:1821
|
JP |
|
Innate Pharma SA
F:IDD
|
FR |
Intrinsic Value
The intrinsic value for
Sumitomo Mitsui Construction Co Ltd (1821) under the Base Case is 638 588.7633 JPY.
Compared with the current market price of 999 999.9999 JPY, the stock appears
Overvalued by 36% .
Do our valuations actually work? See backtest results .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Sumitomo Mitsui Construction Co Ltd.
Fundamental Analysis
Revenue & Expenses Breakdown
Sumitomo Mitsui Construction Co Ltd
Earnings Waterfall
Sumitomo Mitsui Construction Co Ltd
The intrinsic value for
Sumitomo Mitsui Construction Co Ltd (1821) under the Base Case is 638 588.7633 JPY.
Compared with the current market price of 999 999.9999 JPY, the stock appears Overvalued by 36% .